
TSE:CLS
This summary was created by AI, based on 34 opinions in the last 12 months.
Celestica Inc (CLS-T) has garnered attention due to its strong performance in the AI and cloud infrastructure space, demonstrating revenue growth exceeding 50% last quarter. While some analysts see significant upside potential, with price targets around $625, opinions are mixed, with concerns over the stock's valuation, as it has increased substantially over the past year. A common recommendation is to take profits, indicating that the stock is not trading cheaply, especially after a considerable rise. Analysts note that while the stock benefits from the ongoing AI boom and data center developments, its valuation is perceived as stretched by some experts. Thus, investors are advised to exercise caution and consider pullbacks as potential buying opportunities.
One of the great Canadian tech companies. Chart shows a long trend from late 2012 that has been broken recently, but what is interesting is that the recent top, that took place halfway through 2013, was broken. It is kind of testing that top at $11.50-$12. Wouldn’t want to see it break that top, but so far it is reasonably healthy. If you are looking to Buy wait to see if it will hold, and then Buy as it starts to move up.
Has a bit of a more positive chart than the rest of the sector. Made several attempts to break out above $11.40, which it finally did and now it is coming back to test it. Right here at, $11.40-$11.70 is a pretty good entry point. Some of the indicators are kind of coming off and we are getting rid of some of the overbought situation.
Pulled back a month or so ago. When you have Cisco (CSCO-Q) as a customer and it has a slowdown that is a concern. On the other side, one of their competitors had a pretty bad report. Has quite a bit of cash in the balance sheet and if you strip that out it looks very attractive on a multiple basis. Good cash generation. Feels there is a bit of room for the stock to run.
In contract manufacturing, he has seen spots of growth throughout the group, especially the ones in the US. They get going and then they stall. He likes to see more strength. This one has a model price of $17.77, a 66% upside. Thinks we just need a little bit of confidence in those earnings plus a little bit of forward guidance as to if products are sustainable.
There has been a long consolidation from 2011. Broke out in the middle of this year and had a parabolic move. After every parabolic move, it needs a period of consolidation. That is precisely what it is doing right now and is very healthy for the stock. If it can take the old 2011 high out, which he would bet it will, it will be very good. Wait for a breakout before buying. If you own, continue to hold.
Do outsource contract manufacturing. In the top 5% of his database. Over the last 2 years they have been diversifying away from high-volume commodity hand sets, etc., and towards a more stable and high-margin long product cycles that occur in medical and aerospace. Has a 12.5% forecast return on equity and 8.5% trailing free cash flow yield. Cash of $483 million.